Balyasny Asset Management’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-288,612
Closed -$1.08M 2289
2024
Q1
$1.08M Buy
+288,612
New +$1.08M ﹤0.01% 1238
2023
Q4
Sell
-326,770
Closed -$2.73M 2178
2023
Q3
$2.73M Buy
+326,770
New +$2.73M 0.01% 924
2023
Q1
Sell
-349,391
Closed -$2.86M 2518
2022
Q4
$2.86M Buy
+349,391
New +$2.86M 0.01% 929
2022
Q3
Hold
0
2654
2022
Q2
Hold
0
2591
2022
Q1
Sell
-26,309
Closed -$538K 2400
2021
Q4
$538K Buy
+26,309
New +$538K ﹤0.01% 1381
2020
Q3
Sell
-19,029
Closed -$66K 1276
2020
Q2
$66K Buy
+19,029
New +$66K ﹤0.01% 901
2019
Q4
Sell
-651,043
Closed -$3.36M 1262
2019
Q3
$3.36M Sell
651,043
-38,237
-6% -$197K 0.02% 539
2019
Q2
$4.17M Sell
689,280
-749,776
-52% -$4.54M 0.03% 563
2019
Q1
$10.4M Buy
1,439,056
+1,402,467
+3,833% +$10.1M 0.07% 333
2018
Q4
$271K Sell
36,589
-436,767
-92% -$3.23M ﹤0.01% 1147
2018
Q3
$2.56M Buy
+473,356
New +$2.56M 0.01% 720
2018
Q2
Sell
-19,958
Closed -$41K 1833
2018
Q1
$41K Buy
19,958
+662
+3% +$1.36K ﹤0.01% 1677
2017
Q4
$51K Sell
19,296
-14,204
-42% -$37.5K ﹤0.01% 1765
2017
Q3
$176K Buy
+33,500
New +$176K ﹤0.01% 1518
2016
Q4
Hold
0
1250
2016
Q3
Hold
0
1062
2016
Q2
Sell
-11,100
Closed -$94K 1166
2016
Q1
$94K Sell
11,100
-244,556
-96% -$2.07M ﹤0.01% 1002
2015
Q4
$3.36M Buy
+255,656
New +$3.36M 0.02% 489